Aurora O’Brate

2.5k total citations
37 papers, 1.9k citations indexed

About

Aurora O’Brate is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Aurora O’Brate has authored 37 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Molecular Biology and 12 papers in Cell Biology. Recurrent topics in Aurora O’Brate's work include Microtubule and mitosis dynamics (12 papers), Cancer Treatment and Pharmacology (12 papers) and Lung Cancer Treatments and Mutations (10 papers). Aurora O’Brate is often cited by papers focused on Microtubule and mitosis dynamics (12 papers), Cancer Treatment and Pharmacology (12 papers) and Lung Cancer Treatments and Mutations (10 papers). Aurora O’Brate collaborates with scholars based in United States, Spain and Germany. Aurora O’Brate's co-authors include Paraskevi Giannakakou, K. C. Nicolaou, José M. Andreu, Marisa Carbonaro, Rafael Rosell, J. Fernando Dı́az, Ernest Hamel, Mariano Monzó, Mali V. Reddy and Yuefang Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Aurora O’Brate

37 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurora O’Brate United States 22 1.1k 777 585 549 189 37 1.9k
Frank Loganzo United States 26 1.2k 1.1× 1.2k 1.5× 425 0.7× 263 0.5× 169 0.9× 56 2.4k
C. Michael Lin United States 13 1.2k 1.1× 748 1.0× 787 1.3× 252 0.5× 290 1.5× 21 2.7k
Byron H. Long United States 26 1.4k 1.3× 1.3k 1.6× 803 1.4× 395 0.7× 164 0.9× 57 2.5k
Rima Al‐awar Canada 29 1.3k 1.2× 498 0.6× 550 0.9× 140 0.3× 261 1.4× 65 2.2k
Bi‐Ching Sang United States 18 1.2k 1.1× 711 0.9× 337 0.6× 221 0.4× 100 0.5× 30 2.2k
Melanie Valenti United Kingdom 30 1.7k 1.5× 1.1k 1.4× 383 0.7× 233 0.4× 302 1.6× 61 2.6k
Stephen C. Cosenza United States 23 1.1k 1.0× 571 0.7× 460 0.8× 316 0.6× 111 0.6× 55 2.0k
Suzanne B. Buck United States 8 744 0.7× 648 0.8× 547 0.9× 315 0.6× 97 0.5× 10 1.5k
Julian M.C. Golec United States 18 1.7k 1.5× 1.1k 1.4× 247 0.4× 723 1.3× 259 1.4× 24 2.3k
Ulf Peters United States 12 2.4k 2.2× 917 1.2× 517 0.9× 460 0.8× 236 1.2× 17 3.0k

Countries citing papers authored by Aurora O’Brate

Since Specialization
Citations

This map shows the geographic impact of Aurora O’Brate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurora O’Brate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurora O’Brate more than expected).

Fields of papers citing papers by Aurora O’Brate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurora O’Brate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurora O’Brate. The network helps show where Aurora O’Brate may publish in the future.

Co-authorship network of co-authors of Aurora O’Brate

This figure shows the co-authorship network connecting the top 25 collaborators of Aurora O’Brate. A scholar is included among the top collaborators of Aurora O’Brate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurora O’Brate. Aurora O’Brate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rolfo, Christian, Aurora O’Brate, Rolf Bruns, et al.. (2025). Liquid and Tissue Biopsies for Identifying MET Exon 14 Skipping NSCLC: Analyses from the Phase II VISION Study of Tepotinib. Clinical Cancer Research. 31(13). 2675–2684. 1 indexed citations
2.
Pan, Hongming, Jean Frédéric Blanc, Véronique Grando, et al.. (2024). Activity of Tepotinib in Hepatocellular Carcinoma With High-Level MET Amplification: Preclinical and Clinical Evidence. JCO Precision Oncology. 8(8). e2300328–e2300328. 6 indexed citations
3.
Yang, Mo, et al.. (2023). Health Utility Analysis of Tepotinib in Patients With Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping. Value in Health. 26(8). 1155–1163. 5 indexed citations
4.
Carbonaro, Marisa, Daniel Escuín, Aurora O’Brate, Maria Thadani‐Mulero, & Paraskevi Giannakakou. (2012). Microtubules Regulate Hypoxia-inducible Factor-1α Protein Trafficking and Activity. Journal of Biological Chemistry. 287(15). 11859–11869. 61 indexed citations
5.
Kanakkanthara, Arun, Anja Wilmes, Aurora O’Brate, et al.. (2011). Peloruside- and Laulimalide-Resistant Human Ovarian Carcinoma Cells Have βI-Tubulin Mutations and Altered Expression of βII- and βIII-Tubulin Isotypes. Molecular Cancer Therapeutics. 10(8). 1419–1429. 33 indexed citations
6.
Carbonaro, Marisa, Aurora O’Brate, & Paraskevi Giannakakou. (2011). Microtubule disruption targets HIF-1α mRNA to cytoplasmic P-bodies for translational repression. The Journal of Cell Biology. 192(1). 83–99. 76 indexed citations
7.
Nicolaou, K. C., et al.. (2006). Molecular Design and Chemical Synthesis of a Highly Potent Epothilone. ChemMedChem. 1(1). 41–44. 37 indexed citations
8.
Marcus, Adam I., Jun Zhou, Aurora O’Brate, et al.. (2005). The Synergistic Combination of the Farnesyl Transferase Inhibitor Lonafarnib and Paclitaxel Enhances Tubulin Acetylation and Requires a Functional Tubulin Deacetylase. Cancer Research. 65(9). 3883–3893. 93 indexed citations
9.
O’Brate, Aurora, Erik R. Kline, Yue Feng, Mikhail V. Blagosklonny, & Paraskevi Giannakakou. (2005). 2ME2 inhibits HIF-1 mRNA translation and its association with microtubules: Loss of microtubule-dependent HIF regulation in renal carcinoma cells. Cancer Research. 65. 769–769. 1 indexed citations
10.
Wang, Yuefang, Aurora O’Brate, Wei Zhou, & Paraskevi Giannakakou. (2005). Resistance to Microtubule-Stabilizing Drugs Involves Two Eventse: β-Tubulin Mutation in One Allele Followed by Loss of the Second Allele. Cell Cycle. 4(12). 1847–1853. 31 indexed citations
11.
Buey, Rubén M., J. Fernando Dı́az, José M. Andreu, et al.. (2004). Interaction of Epothilone Analogs with the Paclitaxel Binding Site. Chemistry & Biology. 11(2). 225–236. 102 indexed citations
12.
Nicolaou, K. C., Yiwei Li, Kazuyuki Sugita, et al.. (2004). Total Synthesis of Apoptolidin: Completion of the Synthesis and Analogue Synthesis and Evaluation.. ChemInform. 35(14). 1 indexed citations
13.
Nicolaou, K. C., Junliang Hao, Mali V. Reddy, et al.. (2004). Chemistry and Biology of Diazonamide A:  Second Total Synthesis and Biological Investigations. Journal of the American Chemical Society. 126(40). 12897–12906. 145 indexed citations
14.
O’Brate, Aurora & Paraskevi Giannakakou. (2003). The importance of p53 location: nuclear or cytoplasmic zip code?. Drug Resistance Updates. 6(6). 313–322. 173 indexed citations
15.
Nicolaou, K. C., Pradip K. Sasmal, Gerasimos Rassias, et al.. (2003). Design, Synthesis, and Biological Properties of Highly Potent Epothilone B Analogues. Angewandte Chemie International Edition. 42(30). 3515–3520. 61 indexed citations
16.
Nicolaou, K. C., David W. Kim, Rachid Baati, Aurora O’Brate, & Paraskevi Giannakakou. (2003). Total Synthesis and Biological Evaluation of (−)Apicularen A and Analogues Thereof. Chemistry - A European Journal. 9(24). 6177–6191. 55 indexed citations
17.
Rosell, Rafael, Mariano Monzó, Aurora O’Brate, & Miquel Tarón. (2002). Translational oncogenomics: toward rational therapeutic decision-making. Current Opinion in Oncology. 14(2). 171–179. 21 indexed citations
18.
Pryor, Donald E., Aurora O’Brate, Geoffrey Bilcer, et al.. (2002). The Microtubule Stabilizing Agent Laulimalide Does Not Bind in the Taxoid Site, Kills Cells Resistant to Paclitaxel and Epothilones, and May Not Require Its Epoxide Moiety for Activity. Biochemistry. 41(29). 9109–9115. 200 indexed citations
19.
Rosell, Rafael, Miquel Tarón, & Aurora O’Brate. (2001). Predictive molecular markers in non–small cell lung cancer. Current Opinion in Oncology. 13(2). 101–109. 31 indexed citations
20.
O’Brate, Aurora, Miquel Tarón, David R. Gandara, & Rafael Rosell. (2000). Sharing New Approaches to Translational Research in Non-Small Cell Lung Cancer. The Oncologist. 5(6). 514–519. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank Loganzo Breakdown of academic impact, for papers by C. Michael Lin Breakdown of academic impact, for papers by Byron H. Long Breakdown of academic impact, for papers by Rima Al‐awar Breakdown of academic impact, for papers by Bi‐Ching Sang Breakdown of academic impact, for papers by Melanie Valenti Breakdown of academic impact, for papers by Stephen C. Cosenza Breakdown of academic impact, for papers by Suzanne B. Buck Breakdown of academic impact, for papers by Julian M.C. Golec Breakdown of academic impact, for papers by Ulf Peters
Rankless by CCL
2026